KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Intangibles: 2013-2019

Historic Change in Intangibles for Supernus Pharmaceuticals (SUPN) over the last 7 years, with Dec 2019 value amounting to $1.3 million.

  • Supernus Pharmaceuticals' Change in Intangibles was N/A to $453,000 in Q1 2021 from the same period last year, while for Mar 2021 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2019, which is 66.75% up from last year.
  • According to the latest figures from FY2019, Supernus Pharmaceuticals' Change in Intangibles is $1.3 million, which was up 66.75% from $809,000 recorded in FY2018.
  • Supernus Pharmaceuticals' 5-year Change in Intangibles high stood at $18.8 million for FY2016, and its period low was $809,000 during FY2018.
  • Over the past 3 years, Supernus Pharmaceuticals' median Change in Intangibles value was $1.3 million (recorded in 2019), while the average stood at $4.4 million.
  • Per our database at Business Quant, Supernus Pharmaceuticals' Change in Intangibles skyrocketed by 379.01% in 2015 and then plummeted by 92.75% in 2018.
  • Yearly analysis of 5 years shows Supernus Pharmaceuticals' Change in Intangibles stood at $10.9 million in 2015, then surged by 72.56% to $18.8 million in 2016, then slumped by 40.74% to $11.2 million in 2017, then slumped by 92.75% to $809,000 in 2018, then soared by 66.75% to $1.3 million in 2019.